iDEL Therapeutics is a startup based in the United States, most recent round Series A, 1 tracked investor.
Based in the United States, iDEL Therapeutics is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
iDEL Therapeutics is a biotechnology company focused on developing innovative therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.